TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Merck: FDA reviewing tablet to eliminate allergy

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

By The Associated Press
Thursday, March 28, 2013, 12:01 a.m.
 

Drugmaker Merck & Co. says federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that reduces symptoms over time, rather than just temporarily relieving the sneezing and itching.

The treatment, a tablet that dissolves under the tongue, could become the first alternative available in the United States to a long series of uncomfortable allergy shots. Both methods work by gradually desensitizing the patient's immune system to the substance triggering the allergic reaction. Merck's immunotherapy, still unnamed, would be taken daily throughout allergy season.

for three years.

The company, which is based in Whitehouse Station, N.J., also recently applied to the Food and Drug Administration for approval to sell an immunotherapy tablet for ragweed pollen.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Federal agency checking whether Highmark has enough doctors in Medicare plan
  2. Lower gasoline prices fail to spur consumer spending
  3. Retailers that won’t open on Thanksgiving hope move pays off
  4. Westinghouse to construct colossal nuke plant in Turkey
  5. Butler County firm Deep Well Services tackles tough gas wells
  6. Google applies tech to medical device
  7. Health care, gas drilling industries await Gov.-elect Wolf’s footprint
  8. Household debt on the rise after 5-year decline
  9. Oil prices continue descent, dragging market indexes lower
  10. Housing prices nudge upward as more homes on market
  11. Thanksgiving deals called the best
Subscribe today! Click here for our subscription offers.